Your browser doesn't support javascript.
loading
Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment.
Begum, Shahina; Cabrera, Eliazar Sabater; Restrepo, Oscar Herrera; Burman, Cindy; Sohn, Woo-Yun; Kuylen, Elise; Shah, Hiral; Kocaata, Zeki.
Afiliación
  • Begum S; GSK London, London, UK.
  • Cabrera ES; GSK Wavre, Wavre, Belgium. eliazar.x.sabatercabrera@gsk.com.
  • Restrepo OH; GSK Philadelphia, Philadelphia, PA, USA.
  • Burman C; GSK Philadelphia, Philadelphia, PA, USA.
  • Sohn WY; GSK Philadelphia, Philadelphia, PA, USA.
  • Kuylen E; GSK Wavre, Wavre, Belgium.
  • Shah H; GSK London, London, UK.
  • Kocaata Z; GSK Wavre, Wavre, Belgium.
Infect Dis Ther ; 13(9): 2001-2015, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39044053
ABSTRACT

INTRODUCTION:

Invasive meningococcal disease (IMD) is a severe and life-threatening disease. In the United States (US), vaccine coverage with MenACWY and MenB meningococcal vaccines is suboptimal among adolescents/young adults aged 16-23 years. A combined meningococcal vaccine (MenABCWY) could increase convenience (e.g., fewer injections) and improve coverage. The objective was to quantify preferences for hypothetical meningococcal vaccine profiles among adolescents/young adults and parents.

METHODS:

An online discrete choice experiment was conducted among 16- to 23-year-olds, and parents of 16- to 18-year-olds. Attributes (3 × 4) and levels (1 × 2) were based on the literature and focus groups. Participants made ten pair-wise forced trade-off choices, systematically varied using a D-optimal design. Random parameter logit quantified the relative importance of vaccination attributes and estimated the trade-offs. Differences in preferences by subgroups were assessed.

RESULTS:

Totals of 300 adolescents and young adults (median age 20 years) and 300 parents (median age 46 years) completed the survey. Overall, 89.6% of 16- to 23-year-olds and 69.1% of parents preferred a simplified hypothetical meningococcal vaccination profile, e.g., with fewer injections (3 vs. 4) and fewer healthcare provider (HCP) visits (2-3 vs. 4). Having HCP advice and clear Centers for Disease Control and Prevention recommendations impacted vaccination choice, with both groups reporting high trust in HCP information (83.3% among 16- to 23-year-olds; 98.7% among parents). Barriers to vaccination included lack of HCP advice or awareness of meningococcal vaccines, and income level and out-of-pocket costs for parents.

CONCLUSIONS:

Adolescents/young adults and parents demonstrated a significant preference for a meningococcal vaccine that is more convenient (such as combined MenABCWY). Parents' vaccination preferences differed by income level and out-of-pocket costs, suggesting financial barriers to vaccination may exist which could result in IMD prevention inequalities. Findings from this study provide important information to support patient-facing informed policy discussions. A simplified vaccination schedule and strong recommendation could help improve vaccine uptake, schedule compliance, disease prevention, and reduce inequalities in IMD risk and prevention. A graphical abstract is available with this article.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Ther Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Ther Año: 2024 Tipo del documento: Article